238 related articles for article (PubMed ID: 22203741)
1. Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction.
Meyer MR; Amann K; Field AS; Hu C; Hathaway HJ; Kanagy NL; Walker MK; Barton M; Prossnitz ER
Hypertension; 2012 Feb; 59(2):507-12. PubMed ID: 22203741
[TBL] [Abstract][Full Text] [Related]
2. G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity.
Meyer MR; Fredette NC; Barton M; Prossnitz ER
J Endocrinol; 2015 Oct; 227(1):61-9. PubMed ID: 26303299
[TBL] [Abstract][Full Text] [Related]
3. GPER inhibits diabetes-mediated RhoA activation to prevent vascular endothelial dysfunction.
Li Z; Cheng L; Liang H; Duan W; Hu J; Zhi W; Yang J; Liu Z; Zhao M; Liu J
Eur J Cell Biol; 2016 Feb; 95(2):100-13. PubMed ID: 26785611
[TBL] [Abstract][Full Text] [Related]
4. Vasodilatory effects of the selective GPER agonist G-1 is maximal in arteries of postmenopausal women.
Arefin S; Simoncini T; Wieland R; Hammarqvist F; Spina S; Goglia L; Kublickiene K
Maturitas; 2014 Jun; 78(2):123-30. PubMed ID: 24796498
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation.
Gros R; Ding Q; Liu B; Chorazyczewski J; Feldman RD
Am J Physiol Cell Physiol; 2013 Mar; 304(6):C532-40. PubMed ID: 23283935
[TBL] [Abstract][Full Text] [Related]
6. Estrogen Enhances Linkage in the Vascular Endothelial Calmodulin Network via a Feedforward Mechanism at the G Protein-coupled Estrogen Receptor 1.
Tran QK; Firkins R; Giles J; Francis S; Matnishian V; Tran P; VerMeer M; Jasurda J; Burgard MA; Gebert-Oberle B
J Biol Chem; 2016 May; 291(20):10805-23. PubMed ID: 26987903
[TBL] [Abstract][Full Text] [Related]
7. Chronic in vivo or acute in vitro resveratrol attenuates endothelium-dependent cyclooxygenase-mediated contractile signaling in hypertensive rat carotid artery.
Denniss SG; Ford RJ; Smith CS; Jeffery AJ; Rush JW
J Appl Physiol (1985); 2016 May; 120(10):1141-50. PubMed ID: 26917696
[TBL] [Abstract][Full Text] [Related]
8. G-Protein-Coupled Estrogen Receptor Antagonist G15 Decreases Estrogen-Induced Development of Non-Small Cell Lung Cancer.
Liu C; Liao Y; Fan S; Fu X; Xiong J; Zhou S; Zou M; Wang J
Oncol Res; 2019 Feb; 27(3):283-292. PubMed ID: 28877783
[TBL] [Abstract][Full Text] [Related]
9. GPER Mediates Functional Endothelial Aging in Renal Arteries.
Meyer MR; Rosemann T; Barton M; Prossnitz ER
Pharmacology; 2017; 100(3-4):188-193. PubMed ID: 28704834
[TBL] [Abstract][Full Text] [Related]
10. GPER mediates cardiotropic effects in spontaneously hypertensive rat hearts.
De Francesco EM; Angelone T; Pasqua T; Pupo M; Cerra MC; Maggiolini M
PLoS One; 2013; 8(8):e69322. PubMed ID: 23950890
[TBL] [Abstract][Full Text] [Related]
11. The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats.
Tang EH; Jensen BL; Skott O; Leung GP; Feletou M; Man RY; Vanhoutte PM
Cardiovasc Res; 2008 Apr; 78(1):130-8. PubMed ID: 18093985
[TBL] [Abstract][Full Text] [Related]
12. Role of GPER in estrogen-dependent nitric oxide formation and vasodilation.
Fredette NC; Meyer MR; Prossnitz ER
J Steroid Biochem Mol Biol; 2018 Feb; 176():65-72. PubMed ID: 28529128
[TBL] [Abstract][Full Text] [Related]
13. GPER regulates endothelin-dependent vascular tone and intracellular calcium.
Meyer MR; Field AS; Kanagy NL; Barton M; Prossnitz ER
Life Sci; 2012 Oct; 91(13-14):623-7. PubMed ID: 22326502
[TBL] [Abstract][Full Text] [Related]
14. G protein-coupled estrogen receptor agonist improves cerebral microvascular function after hypoxia/reoxygenation injury in male and female rats.
Murata T; Dietrich HH; Xiang C; Dacey RG
Stroke; 2013 Mar; 44(3):779-85. PubMed ID: 23362079
[TBL] [Abstract][Full Text] [Related]
15. Vasoconstriction induced by G1, a G-protein-coupled oestrogen receptor1 (GPER-1) agonist, in the isolated perfused rat kidney.
Kurt AH; Buyukafsar K
Eur J Pharmacol; 2013 Feb; 702(1-3):71-8. PubMed ID: 23376418
[TBL] [Abstract][Full Text] [Related]
16. Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors.
Félétou M; Verbeuren TJ; Vanhoutte PM
Br J Pharmacol; 2009 Feb; 156(4):563-74. PubMed ID: 19154435
[TBL] [Abstract][Full Text] [Related]
17. G protein-coupled estrogen receptor-1 is involved in the protective effect of protocatechuic aldehyde against endothelial dysfunction.
Kong BS; Cho YH; Lee EJ
PLoS One; 2014; 9(11):e113242. PubMed ID: 25411835
[TBL] [Abstract][Full Text] [Related]
18. Vascular effects of aldosterone: sorting out the receptors and the ligands.
Feldman RD; Gros R
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):916-21. PubMed ID: 23902478
[TBL] [Abstract][Full Text] [Related]
19. G protein-coupled estrogen receptor protects from atherosclerosis.
Meyer MR; Fredette NC; Howard TA; Hu C; Ramesh C; Daniel C; Amann K; Arterburn JB; Barton M; Prossnitz ER
Sci Rep; 2014 Dec; 4():7564. PubMed ID: 25532911
[TBL] [Abstract][Full Text] [Related]
20. GPER agonist dilates mesenteric arteries via PI3K-Akt-eNOS and potassium channels in both sexes.
Peixoto P; Aires RD; Lemos VS; Bissoli NS; Santos RLD
Life Sci; 2017 Aug; 183():21-27. PubMed ID: 28645860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
